203 related articles for article (PubMed ID: 30987717)
61. Effects of Freeze-Thaw Cycles of Blood Samples on High-Coverage Quantitative Metabolomics.
Chen D; Han W; Huan T; Li L; Li L
Anal Chem; 2020 Jul; 92(13):9265-9272. PubMed ID: 32469506
[TBL] [Abstract][Full Text] [Related]
62. Chemical Isotope Labeling LC-MS for Human Blood Metabolome Analysis.
Han W; Li L
Methods Mol Biol; 2018; 1730():213-225. PubMed ID: 29363075
[TBL] [Abstract][Full Text] [Related]
63. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
Chen D; Han W; Su X; Li L; Li L
Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
[TBL] [Abstract][Full Text] [Related]
64. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA
Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658
[TBL] [Abstract][Full Text] [Related]
65. Bretschneider solution-induced alterations in the urine metabolome in cardiac surgery patients.
Lee CC; Hsieh YJ; Chen SW; Fu SH; Hsu CW; Wu CC; Han W; Li Y; Huan T; Chang YS; Yu JS; Li L; Chang CH; Chen YT
Sci Rep; 2018 Dec; 8(1):17774. PubMed ID: 30538262
[TBL] [Abstract][Full Text] [Related]
66. Metabolomic Coverage of Chemical-Group-Submetabolome Analysis: Group Classification and Four-Channel Chemical Isotope Labeling LC-MS.
Zhao S; Li H; Han W; Chan W; Li L
Anal Chem; 2019 Sep; 91(18):12108-12115. PubMed ID: 31441644
[TBL] [Abstract][Full Text] [Related]
67. Metabolic profiling associated with autophagy of human placenta-derived mesenchymal stem cells by chemical isotope labeling LC-MS.
Sun Y; Chen D; Liu J; Xu Y; Shi X; Luo X; Pan Q; Yu J; Yang J; Cao H; Li L; Li L
Exp Cell Res; 2018 Nov; 372(1):52-60. PubMed ID: 30227120
[TBL] [Abstract][Full Text] [Related]
68. Retention time shift analysis and correction in chemical isotope labeling liquid chromatography/mass spectrometry for metabolome analysis.
Li Y; Li L
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8643. PubMed ID: 31705568
[TBL] [Abstract][Full Text] [Related]
69. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
Huang Z; Lin L; Gao Y; Chen Y; Yan X; Xing J; Hang W
Mol Cell Proteomics; 2011 Oct; 10(10):M111.007922. PubMed ID: 21799048
[TBL] [Abstract][Full Text] [Related]
70. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
Godoy AT; Eberlin MN; Simionato AVC
Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
[TBL] [Abstract][Full Text] [Related]
71. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
[TBL] [Abstract][Full Text] [Related]
72. Discovery and validation of bladder cancer related excreted nucleosides biomarkers by dilution approach in cell culture supernatant and urine using UHPLC-MS/MS.
Chang Q; Chen P; Yin J; Liang G; Dai Y; Guan Y; Chen Y; Zhao Y; Lu YJ; Zhang L; Song D; Yuan H
J Proteomics; 2023 Jan; 270():104737. PubMed ID: 36174950
[TBL] [Abstract][Full Text] [Related]
73. Quantitative liquid chromatography-electrospray ionization-mass spectrometry analysis of amine-containing metabolites derivatized with cyanuric chloride and methylamine isotopologues.
Lee DY; Chang GD
J Chromatogr A; 2015 Apr; 1388():60-8. PubMed ID: 25731825
[TBL] [Abstract][Full Text] [Related]
74. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.
Kreunin P; Zhao J; Rosser C; Urquidi V; Lubman DM; Goodison S
J Proteome Res; 2007 Jul; 6(7):2631-9. PubMed ID: 17518487
[TBL] [Abstract][Full Text] [Related]
75. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
76. Effects of sample injection amount and time-of-flight mass spectrometric detection dynamic range on metabolome analysis by high-performance chemical isotope labeling LC-MS.
Zhou R; Li L
J Proteomics; 2015 Apr; 118():130-9. PubMed ID: 25134441
[TBL] [Abstract][Full Text] [Related]
77. Development of a simple and efficient method of harvesting and lysing adherent mammalian cells for chemical isotope labeling LC-MS-based cellular metabolomics.
Luo X; Gu X; Li L
Anal Chim Acta; 2018 Dec; 1037():97-106. PubMed ID: 30292319
[TBL] [Abstract][Full Text] [Related]
78. Simultaneous quantification of free fatty acids and acylcarnitines in plasma samples using dansylhydrazine labeling and liquid chromatography-triple quadrupole mass spectrometry.
Chen GY; Zhang Q
Anal Bioanal Chem; 2020 May; 412(12):2841-2849. PubMed ID: 32078005
[TBL] [Abstract][Full Text] [Related]
79. Quantitative determination of potential urine biomarkers of respiratory illnesses using new targeted metabolomic approach.
Khamis MM; Adamko DJ; Purves RW; El-Aneed A
Anal Chim Acta; 2019 Jan; 1047():81-92. PubMed ID: 30567667
[TBL] [Abstract][Full Text] [Related]
80. Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
Shao CH; Chen CL; Lin JY; Chen CJ; Fu SH; Chen YT; Chang YS; Yu JS; Tsui KH; Juo CG; Wu KP
Oncotarget; 2017 Jun; 8(24):38802-38810. PubMed ID: 28415579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
